The estimated Net Worth of Nancy Killefer is at least $3.04 Millón dollars as of 21 May 2024. Ms. Killefer owns over 8,663 units of Cardinal Health stock worth over $2,738,649 and over the last 10 years she sold CAH stock worth over $0. In addition, she makes $296,521 as Independent Director at Cardinal Health.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Killefer CAH stock SEC Form 4 insiders trading
Nancy has made over 24 trades of the Cardinal Health stock since 2016, according to the Form 4 filled with the SEC. Most recently she exercised 8,663 units of CAH stock worth $981,951 on 21 May 2024.
The largest trade she's ever made was exercising 9,067 units of Cardinal Health stock on 17 May 2023 worth over $1,027,744. On average, Nancy trades about 801 units every 43 days since 2014. As of 21 May 2024 she still owns at least 24,161 units of Cardinal Health stock.
You can see the complete history of Ms. Killefer stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Nancy Killefer biography
Nancy Killefer serves as Independent Director of the Company. Ms. Killefer served as Senior Partner of McKinsey & Company, Inc., a global management consulting firm, from 1992 until 2013. She joined McKinsey in 1979 and held a number of key leadership roles, including serving as a member of the firm’s governing board. Ms. Killefer founded McKinsey’s Public Sector Practice in 2007 and served as its managing partner until her retirement. She also served as Assistant Secretary for Management, Chief Financial Officer and Chief Operating Officer for the U.S. Department of Treasury from 1997 to 2000. Having served in key leadership positions in both the public and private sectors and provided strategic counsel to healthcare and consumer-based companies during her 30 years with McKinsey, Ms. Killefer brings to the Board substantial experience in the areas of strategic planning, including healthcare strategy, and marketing and brand-building. Her extensive experience as managing partner of McKinsey’s Public Sector Practice and as a chief financial officer of a government agency provides valuable insights in the areas of government relations, public policy and finance. Ms. Killefer also brings to the Board valuable perspectives and insights from her service on the board of directors of Avon Products, including its Compensation and Management Development Committee, and Taubman Centers and her prior service on the boards of directors of CSRA, Inc. (including as its independent chair), Computer Sciences Corporation and The Advisory Board.
What is the salary of Nancy Killefer?
As the Independent Director of Cardinal Health, the total compensation of Nancy Killefer at Cardinal Health is $296,521. There are 19 executives at Cardinal Health getting paid more, with Michael Kaufmann having the highest compensation of $14,217,100.
How old is Nancy Killefer?
Nancy Killefer is 66, she's been the Independent Director of Cardinal Health since 2015. There are 5 older and 21 younger executives at Cardinal Health. The oldest executive at Cardinal Health, Inc. is John Losh, 74, who is the Independent Director.
What's Nancy Killefer's mailing address?
Nancy's mailing address filed with the SEC is C/O META PLATFORMS, INC., 1 META WAY, MENLO PARK, CA, 94025.
Insiders trading at Cardinal Health
Over the last 23 years, insiders at Cardinal Health have traded over $135,712,519 worth of Cardinal Health stock and bought 2,709 units worth $199,571 . The most active insiders traders include Dean A Scarborough, George S Barrett y Jeffrey William Henderson. On average, Cardinal Health executives and independent directors trade stock every 32 days with the average trade being worth of $5,146,997. The most recent stock trade was executed by Jessica L Mayer on 21 August 2024, trading 16,573 units of CAH stock currently worth $1,812,920.
What does Cardinal Health do?
cardinal health, inc. (nyse: cah), is a global integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. the company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. cardinal health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. backed by nearly 100 years of experience, with more than 37,000 employees in nearly 60 countries, cardinal health ranks among the top 25 on the fortune 500. for more information, visit cardinalhealth.com, follow @cardinalhealth on twitter.
What does Cardinal Health's logo look like?
Complete history of Ms. Killefer stock trades at Meta Platforms Inc, Cardinal Health, Taubman Centers y Certara
Cardinal Health executives and stock owners
Cardinal Health executives and other stock owners filed with the SEC include:
-
Michael Kaufmann,
Chief Executive Officer, Director -
Victor Crawford,
Chief Executive Officer - Pharmaceutical Segment -
Jason Hollar,
Chief Financial Officer -
Stephen Mason,
Chief Executive Officer - Medical Segment -
Jessica Mayer,
Chief Legal and Compliance Officer -
Michael C. Kaufmann,
CEO & Director -
David Evans,
Independent Director -
Victor L. Crawford,
Chief Exec. Officer of Pharmaceutical Segment -
Jason M. Hollar,
Chief Financial Officer -
Stephen M. Mason,
Chief Exec. Officer of Medical Segment -
Jessica L. Mayer,
Chief Legal & Compliance Officer -
Gregory Kenny,
Independent Non-Executive Chairman of the Board -
Carrie Cox,
Independent Director -
John Losh,
Independent Director -
Bruce Downey,
Independent Director -
Dean Scarborough,
Independent Director -
Patricia Hemingway Hall,
Independent Director -
John Weiland,
Independent Director -
Calvin Darden,
Independent Director -
Nancy Killefer,
Independent Director -
Akhil Johri,
Independent Director -
Sheri Edison,
Independent Director -
Brian Rice,
Executive Vice President, Chief Information Officer and Customer Support Services -
Ola Snow,
Chief Human Resource Officer -
Dr. Michele A. M. Holcomb Ph.D.,
Exec. VP of Strategy & Corp. Devel. and Chief Strategy & Bus. Devel. Officer -
Brian S. Rice,
Chief Information Officer, Exec. VP & Global Bus. Services -
Craig Cowman,
Exec. VP of Global Sourcing -
Kevin Moran,
VP of Investor Relations -
Patricia M. English,
Sr. VP & Chief Accounting Officer -
Pamela O. Kimmet,
Chief Human Resources Officer -
Michele Holcomb,
EVP - Strategy & Corp. Dev. -
Falk T Stephen,
EVP, Gen. Counsel & Corp. Sec. -
David P King,
Director -
Craig S Morford,
Chief Compliance Officer -
Colleen F. Arnold,
Director -
Stuart G Laws,
SVP & Chief Accounting Officer -
Donald M Jr. Casey,
CEO, Medical Segment -
Clayton M Jones,
Director -
David J Anderson,
Director -
Patricia Morrison,
Chief Information Officer -
Meghan Fitzgerald,
EVP, Strategy & Health Policy -
Carole S Watkins,
EVP - Human Resources -
Jon L Giacomin,
CEO, Medical Segment -
George S Barrett,
Chairman and CEO -
J Michael Losh,
Director -
Deborah Weitzman,
CEO, PSS Segment -
Jeffrey William Henderson,
Executive Vice President -
David W Raisbeck,
Director -
Michael A Lynch,
CEO, Medical Segment -
Glenn Britt,
Director -
Jean G Spaulding,
Director -
John F Finn,
Director -
Richard C Notebaert,
Director -
Mark R Blake,
EVP -- Strategy & Corp. Dev. -
James J Md Mongan,
Director -
Jorge M Gomez,
Chief Financial Officer -
Michael D Ohalleran,
Director -
Vivek Jain,
EVP - Corp Develop. & Strategy -
George H Conrades,
Director -
Ivan K Fong,
EVP, CLO & Secretary -
Robert D Walter,
Chairman and CEO -
David L Schlotterbeck,
Chmn & CEO-Clncl Techn & Svcs -
John B Mccoy,
Director -
Philip L Francis,
Director -
Matthew D Walter,
Director -
R Kerry Clark,
President and CEO -
Daniel J Walsh,
EVP, Chf Ethcs & Compl Offcr -
Mark W Parrish,
EVP; Group Pres.-Pharm. Distr. -
John F Havens,
Director -
David Bing,
Director -
Gary S Jensen,
SVP - Corporate Controller -
Robert L Gerbig,
Director -
Ronald K Labrum,
CEO-Healthcare Supply Chn Svc -
Brendan A Ford,
EVP - Corp. Development -
Anthony J Rucci,
EVP & Chief Admin. Officer -
Joseph C Papa,
Chmn & CEO, Pharm Techn & Svcs -
Stephen S Thomas,
EVP-Group Pres.-AIS -
Gary D Dolch,
EVP - Quality & Reg. Affairs -
George L Fotiades,
President & COO -
Eric Slusser,
SVP-Finance, CAO & Cntrllr -
Paul S Williams,
EVP, CLO & Secretary -
Jody R Davids,
EVP & CIO -
Richard J Miller,
EVP & CFO -
Aaron E Alt,
Chief Financial Officer -
Robert Azelby,
Director -
Patricia M English,
Chief Accounting Officer -
Christine Mundkur,
Director -
Steven Barg,
Director -
Michelle Brennan,
Director -
Michelle D. Greene,
Chief Information Officer -
Mary C. Scherer,
Chief Accounting Officer